<bill session="108" type="h" number="1736" updated="2023-01-15T23:18:05Z">
  <state datetime="2003-04-10">REFERRED</state>
  <status>
    <introduced datetime="2003-04-10"/>
  </status>
  <introduced datetime="2003-04-10"/>
  <titles>
    <title type="display">Sickle Cell Treatment Act of 2003</title>
    <title type="official" as="introduced">To amend title XIX of the Social Security Act to include primary and secondary preventative medical strategies for children and adults with Sickle Cell Disease as medical assistance under the Medicaid Program, and for other purposes.</title>
    <title type="short" as="introduced">Sickle Cell Treatment Act of 2003</title>
  </titles>
  <sponsor bioguide_id="D000096"/>
  <cosponsors>
    <cosponsor bioguide_id="B001241" joined="2004-02-24"/>
    <cosponsor bioguide_id="B000755" joined="2003-05-13"/>
    <cosponsor bioguide_id="B000911" joined="2003-06-10"/>
    <cosponsor bioguide_id="B001135" joined="2003-04-10"/>
    <cosponsor bioguide_id="C001037" joined="2003-05-13"/>
    <cosponsor bioguide_id="C000380" joined="2003-05-13"/>
    <cosponsor bioguide_id="C001049" joined="2003-05-20"/>
    <cosponsor bioguide_id="C000537" joined="2003-05-20"/>
    <cosponsor bioguide_id="C000714" joined="2003-06-02"/>
    <cosponsor bioguide_id="C000984" joined="2003-05-20"/>
    <cosponsor bioguide_id="D000602" joined="2003-06-10"/>
    <cosponsor bioguide_id="D000216" joined="2004-02-24"/>
    <cosponsor bioguide_id="D000275" joined="2003-05-21"/>
    <cosponsor bioguide_id="E000287" joined="2004-06-18"/>
    <cosponsor bioguide_id="E000179" joined="2003-05-21"/>
    <cosponsor bioguide_id="E000226" joined="2004-06-18"/>
    <cosponsor bioguide_id="F000043" joined="2003-06-19"/>
    <cosponsor bioguide_id="F000116" joined="2004-02-24"/>
    <cosponsor bioguide_id="F000392" joined="2004-02-24"/>
    <cosponsor bioguide_id="G000410" joined="2003-05-21"/>
    <cosponsor bioguide_id="H000324" joined="2004-04-01"/>
    <cosponsor bioguide_id="I000057" joined="2003-06-10"/>
    <cosponsor bioguide_id="J000032" joined="2003-05-20"/>
    <cosponsor bioguide_id="J000070" joined="2003-05-13"/>
    <cosponsor bioguide_id="J000110" joined="2004-02-24"/>
    <cosponsor bioguide_id="J000126" joined="2003-06-19"/>
    <cosponsor bioguide_id="J000284" joined="2003-05-13"/>
    <cosponsor bioguide_id="K000180" joined="2003-05-13"/>
    <cosponsor bioguide_id="L000552" joined="2003-11-21"/>
    <cosponsor bioguide_id="L000551" joined="2003-05-20"/>
    <cosponsor bioguide_id="L000287" joined="2003-06-10"/>
    <cosponsor bioguide_id="M000087" joined="2003-05-13"/>
    <cosponsor bioguide_id="M000404" joined="2004-04-01"/>
    <cosponsor bioguide_id="M000485" joined="2004-07-22"/>
    <cosponsor bioguide_id="M000714" joined="2003-05-13"/>
    <cosponsor bioguide_id="M001154" joined="2004-05-20"/>
    <cosponsor bioguide_id="N000147" joined="2003-05-21"/>
    <cosponsor bioguide_id="N000159" joined="2003-05-21"/>
    <cosponsor bioguide_id="O000159" joined="2003-05-13"/>
    <cosponsor bioguide_id="P000149" joined="2003-05-13"/>
    <cosponsor bioguide_id="P000523" joined="2004-04-22"/>
    <cosponsor bioguide_id="R000053" joined="2003-05-13"/>
    <cosponsor bioguide_id="R000515" joined="2003-04-10"/>
    <cosponsor bioguide_id="S001145" joined="2003-06-10"/>
    <cosponsor bioguide_id="S001157" joined="2003-06-10"/>
    <cosponsor bioguide_id="S000185" joined="2003-05-20"/>
    <cosponsor bioguide_id="S000364" joined="2003-04-10"/>
    <cosponsor bioguide_id="S000480" joined="2004-02-24"/>
    <cosponsor bioguide_id="S000672" joined="2004-04-01"/>
    <cosponsor bioguide_id="T000326" joined="2003-05-13"/>
    <cosponsor bioguide_id="V000108" joined="2004-01-28"/>
    <cosponsor bioguide_id="W000794" joined="2003-05-20"/>
    <cosponsor bioguide_id="W000784" joined="2003-05-21"/>
  </cosponsors>
  <actions>
    <action datetime="2003-04-10">
      <text>Introduced in House</text>
    </action>
    <action datetime="2003-04-10" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2003-04-24">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2003-09-30">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR H9003"/>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="108" type="s" number="874" relation="identical"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Blood transfusions"/>
    <term name="Case management"/>
    <term name="Child health"/>
    <term name="Communication in medicine"/>
    <term name="Community health services"/>
    <term name="Congress"/>
    <term name="Congressional reporting requirements"/>
    <term name="Continuing education"/>
    <term name="Continuum of care"/>
    <term name="Economics and Public Finance"/>
    <term name="Education"/>
    <term name="Families"/>
    <term name="Federal aid to child health services"/>
    <term name="Federal aid to health facilities"/>
    <term name="Genetic counseling"/>
    <term name="Government Operations and Politics"/>
    <term name="Health education"/>
    <term name="Health insurance"/>
    <term name="Higher education"/>
    <term name="Medicaid"/>
    <term name="Medical education"/>
    <term name="Medical screening"/>
    <term name="Medical tests"/>
    <term name="Medically uninsured"/>
    <term name="Nursing education"/>
    <term name="Poor children"/>
    <term name="Preventive medicine"/>
    <term name="Sickle cell anemia"/>
    <term name="Social Welfare"/>
    <term name="Stroke"/>
  </subjects>
  <amendments/>
  <summary date="2006-11-28T17:35:40Z" status="Introduced in House">Sickle Cell Treatment Act of 2003 - Amends title XIX (Medicaid) of the Social Security Act (SSA) to include primary and secondary preventative medical strategies, treatment, and services, including genetic counseling and testing, for individuals who have Sickle Cell Disease as medical assistance under the Medicaid program.Directs the Administrator of the Health Resources and Services Administration to conduct a demonstration program for the development and establishment of systemic mechanisms, including a National Coordinating Center, to improve the prevention and treatment of Sickle Cell Disease.</summary>
</bill>
